{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"11.4","upperLimit":"35.1","value":"26.7"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"30"}],"units":"Participants"}],"description":"Post follow-up progression free survival at time of analysis.","dispersionType":"95% Confidence Interval","groups":[{"description":"The investigational drug used in this study is axitinib, and is available as tablets.","id":"OG000","title":"Axitinib Administration"}],"paramType":"MEDIAN","populationDescription":"All participants.","reportingStatus":"POSTED","timeFrame":"Up to 36 Months","title":"Median Progression Free Survival","type":"PRIMARY","unitOfMeasure":"months"}